Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Tales Of Health Insurance Plights Highlight Overhaul Efforts
Analysts say many in America take jobs they otherwise wouldn"t simply for the health insurance coverage, Reuters/Boston Globe reports. "It is a situation most Europeans, Canadians and others who enjoy national health services would find bewildering if not appalling and is one factor fueling the drive to reform the hugely expensive U.S. healthcare system. ò€¦ U.S. company healthcare plans are usually subsidized by the employer. They are much more affordable and comprehensive than private plans that can exceed a $1,000 a month for a family, a huge burden for most households."
generic viagra online
Research Considers Lean Mass Better For Developing Bones
South Dakota State University research shows that a child with leaner body mass, or muscle, builds bigger bones than a child who weighs the same but has a greater percentage of fat.
News of the day
ADHD Genes Found; Known To Play Roles In Neurodevelopment
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD. Many of those genes were already known to be important for learning, behavior, brain function and neurodevelopment, but had not been previously associated with ADHD.
Mental Health

MHRA Manufacturing Licence For Avecia Biologics

Avecia Biologics has announced it has received a Manufacturer"s Licence from the UK"s Medicines and Healthcare products Regulatory Agency (MHRA). The Licence authorises commercial manufacturing at the company"s Tees Valley, UK site and comes three months after the company successfully underwent its first FDA Pre-Approval Inspection. Avecia Biologics has been engaged in the development of innovative bioprocesses for over 30 years and has been making GMP material for clinical development for over 10 years. Based in the north-east of England, Avecia operates one of Europe"s largest cGMP contract manufacturing facilities and process development groups for microbial protein biologics, offering flexible capacity from 100L - 5000L for all stages of the product pipeline. Steve Bagshaw, president of Avecia Biologics, said "we are immensely proud of achieving this significant milestone in our company"s development. It truly confirms us in the top tier of contract manufacturers for microbial biologics and we look forward to continuing to build on this success with our client partners". Avecia Biologics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009